Date |
Time |
Source |
Heading |
21/11/2023 | 09:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
18/11/2023 | 08:15 | EDGAR2 | Form 8-K - Current report |
15/11/2023 | 08:35 | GLOBE | ZyVersa Therapeutics Reports Third Quarter 2023 Corporate.. |
09/11/2023 | 23:35 | GLOBE | ZyVersa Therapeutics Announces Article Published in.. |
06/11/2023 | 23:05 | GLOBE | ZyVersa Therapeutics Announces Article in Peer-Reviewed.. |
03/11/2023 | 07:37 | EDGAR2 | Form 8-K - Current report |
01/11/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces Publication in Molecular.. |
25/10/2023 | 21:50 | GLOBE | ZyVersa Therapeutics Announces Research Published in the.. |
25/10/2023 | 07:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
23/10/2023 | 15:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
18/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces a Publication in the.. |
18/10/2023 | 07:15 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
11/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces Peer-Reviewed Publication in.. |
04/10/2023 | 22:05 | GLOBE | ZyVersa Therapeutics Announces New Peer-Reviewed Publication.. |
27/9/2023 | 21:07 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate.. |
22/9/2023 | 20:35 | GLOBE | ZyVersa Therapeutics Announces Research Published in The.. |
21/9/2023 | 07:15 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
14/9/2023 | 21:00 | EDGAR2 | Form 8-K - Current report |
14/9/2023 | 06:57 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
14/9/2023 | 06:40 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
12/9/2023 | 20:30 | GLOBE | ZyVersa Therapeutics Announces Research Published in.. |
09/9/2023 | 06:20 | EDGAR2 | Form 8-K - Current report |
02/9/2023 | 06:45 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
22/8/2023 | 06:15 | GLOBE | ZyVersa Therapeutics Reports Second Quarter 2023 Corporate.. |
22/8/2023 | 06:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19/8/2023 | 06:13 | EDGAR2 | Form 8-K - Current report |
15/8/2023 | 22:26 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
03/8/2023 | 21:49 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
27/7/2023 | 07:27 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
27/7/2023 | 07:11 | EDGAR2 | Form 8-K - Current report |
27/7/2023 | 06:21 | EDGAR2 | Form POS EX - Post-effective amendment adding exhibits to.. |
24/7/2023 | 22:00 | GLOBE | ZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million.. |
17/7/2023 | 21:38 | GLOBE | ZyVersa Therapeutics Announces Publication in the Journal,.. |
14/7/2023 | 21:37 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited.. |
10/7/2023 | 21:37 | GLOBE | ZyVersa Therapeutics Announces Publication in the Journal.. |
08/7/2023 | 05:44 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
07/7/2023 | 21:37 | GLOBE | European Patent Granted for ZyVersa Therapeutics' Lead.. |
01/7/2023 | 07:01 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
28/6/2023 | 21:37 | GLOBE | ZyVersa Therapeutics Announces Publication in Clinical.. |
21/6/2023 | 06:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Journal of.. |
13/6/2023 | 22:07 | GLOBE | ZyVersa Therapeutics Publishes New White Paper Detailing the.. |
06/6/2023 | 23:07 | GLOBE | European Patent Office to Grant ZyVersa Therapeutics’ Patent.. |
25/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Frontiers in.. |
20/5/2023 | 06:15 | GLOBE | ZyVersa Therapeutics Announces Changes to ZyVersa’s Board of.. |
15/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces Article Published in.. |
12/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Reports First Quarter 2023 Corporate.. |
11/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate.. |
09/5/2023 | 23:05 | GLOBE | ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate.. |
04/5/2023 | 23:07 | GLOBE | ZyVersa Therapeutics Announces a Publication in Hepatology.. |
02/5/2023 | 08:30 | GLOBE | ZyVersa Therapeutics, Inc. Announces Closing of $11.0.. |